---

---

report   crawled time : 12:20   

save search

---

Intchains Group Limited to Report Unaudited Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
Published: 2024-02-18 (Crawled : 12:20) - globenewswire.com
ICG | $8.17 -0.61% 100 |

n/a

| Email alert Add to watchlist
report year group financial results

---

ZORYVE® (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids
Published: 2024-01-14 (Crawled : 12:20) - arcutis.com
ARQT | $9.09 -3.81% -3.96% 4.5M |

Health Technology

| Email alert Add to watchlist
zoryve dermatitis response

---

Completion of the Third Tranche of Stellantis Share Buyback Program and Weekly Report (December 1-7, 2023)
Published: 2023-12-09 (Crawled : 12:20) - globenewswire.com
STLA | News | $25.77 0.08% -0.66% 6M |

Manufacturing

| Email alert Add to watchlist
report

---

Talent Acquisition Solutions Market Share Research Report [2023-2030] | 102 Pages – Benzinga
Published: 2023-09-17 (Crawled : 12:20) - spacfeed.com
VHAQ | $10.81 0.0% 990 |

| Email alert Add to watchlist
report acquisition research solutions market

---

BOS Reports Financial Results for the Second Quarter of the Year 2023
Published: 2023-08-22 (Crawled : 12:20) - globenewswire.com
BOSC | $2.79 -1.4% -1.42% 18K |

Electronic Technology

| -21.47% | O: 3.67% H: 0.0% C: -1.09%
year financial results

---

Impact of Ardmore’s Energy Transition Plan highlighted in Sustainability Report
Published: 2023-08-22 (Crawled : 12:20) - ardmoreshipping.com
ASC | $15.88 1.86% 0.0% 470K |

Transportation

| 17.46% | O: 0.3% H: 0.66% C: -1.92%
energy report impact

---

ToughBuilt Industries to Report Second Quarter 2023 Financial Results on August 22, 2023
Published: 2023-08-17 (Crawled : 12:20) - globenewswire.com
TBLT | $2.26 -1.74% -1.77% 54K |

Consumer Non-Durables

| -87.14% | O: 2.61% H: 1.74% C: -2.58%
report financial results

---

Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
Published: 2023-08-17 (Crawled : 12:20) - jaguarhealth.gcs-web.com
JAGX | $0.158 -10.79% -12.09% 30M |

Health Technology

| -70.2% | O: -4.06% H: 0.41% C: -2.97%
diarrhea health cancer treatment family crofelemer trial

---

Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K |

Health Technology

| -69.52% | O: -1.9% H: 6.8% C: 6.14%
update financial results

---

Ascendis Pharma to Report Second Quarter 2023 Financial Results and Provide Business Update on September 5, 2023
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
ASND | $140.19 -0.5% -0.5% 270K |

Health Technology

| 54.08% | O: 1.68% H: 2.74% C: 0.0%
pharma report business update financial results

---

SoundThinking, Inc. Releases Second ESG Report: Addressing and Enabling Equitable Outcomes for Public Safety and Social Good
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
SSTI | $13.33 -0.3% -0.3% 73K |

Electronic Technology

| -33.02% | O: 9.7% H: 3.32% C: 0.96%
enabling esg

---

Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CLRB | $3.02 -0.66% -0.66% 810K |

Health Technology

| 89.37% | O: -1.88% H: 6.37% C: 3.82%
update financial results

---

BTCS Reports Q2 2023 Results
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CRCW | News | $0.0015 27.78% 8.5M |

Information

| 13.33% | O: 0.0% H: 0.0% C: -1.0%
BTCS | $1.42 -2.07% -2.11% 32K |

Manufacturing

| 35.24% | O: 0.0% H: 1.87% C: 0.95%
results

---

Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ELOX | $0.94 -51.57% 93K |

Health Technology

| -83.16% | O: 5.05% H: 20.04% C: 14.83%
business update pharmaceuticals financial results

---

Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
NMRD | $0.0798 -28.78% 28K |

Health Technology

| -89.74% | O: 19.29% H: 4.23% C: -14.37%
business update medical results

---

ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CFRX | $0.05 0.0% 910K |

Health Technology

| -94.76% | O: 4.71% H: 0.0% C: -4.01%
business update financial results

---

ARRIVAL to Report Second Quarter 2023 Business Updates in Early September 2023
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| -73.17% | O: -4.88% H: 1.03% C: -2.05%
report business

---

Integra Files Maiden Preliminary Economic Assessment Technical Report for Wildcat & Mountain View Projects
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ITRG | $0.87 -0.12% -1.24% 150K |

Non-Energy Minerals

| 0.54% | O: 1.7% H: 1.14% C: -3.63%
report

---

CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Reiterates Upcoming Milestones
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
CNSP | $0.1934 -5.2% -5.48% 87K |

Health Technology

| -90.15% | O: -2.46% H: 2.53% C: -10.61%
pharmaceuticals financial results

---

Cybin Reports First Quarter Financial Results and Recent Business Highlights
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
CYBN | $0.3677 -0.6% 0.35% 1.8M |

n/a

| 13.15% | O: 2.63% H: 4.23% C: 1.31%
business financial results

---

Gainers vs Losers

67%

33%

Top 10 Gainers

---

Your saved searches

---